meow Mechanism of Indications Contraindication Side Nursing

Action Effects Responsibilities

CNS: Before:
drowsiness,  Take an
depress appropriate
reflexes, seizure precaution.
placid
paralysis, During:
hypothermia  Check
CV: Magnesium
hypotension, level repeat
flushing doses.
bradycardia, Disappearance
circulatory of knee, Jerl
collapse, and patellar
depress reflexes is a
cardiac sign of
function impeding
Skin: magnesium
diaphoresis toxicity.

 Monitor urine
intake and
output.

After:
 Observe
neonates for
signs of
magnesium
toxicity.
Drug Name Dosages Therapeutic Indications Adverse Contraindicati Nursing
Actions effects ons Responsibilities
Generic Drug: PO Betamethaso Systemic Sodium and Hypersensitivi Assessment
Betamethasone Allergic and ne is a administration fluid ty; systemic
inflammatory corticosteroi retention, fungal or  History
Brand Name: disorders; d with mainly  Hypercal potassium acute (Systemic
Celestone, congenital glucocorticoi cemia and calcium infections administration):
Celestone adrenal d activity. It associate depletion. Infections, fungal
Soluspan, hyperplasia prevents and d with Muscle infections,
Betaject, 0.5-5mg/day. by controlling cancer wasting, amebiasis, vaccinia
Betamethasone IM the rate of  Short- weakness, and varicella, and
IM/PO Allergic and protein term osteoporosi antibiotic-resistant
inflammatory synthesis, manage s.GI infections; kidney
Classification: disorders as depressing ment of disturbance or liver disease;
Corticosteroids betamethasone the migration inflamm s and hypothyroidism;
Na phosphate of atory bleeding. ulcerative colitis
and polymorphon and Increased with impending
betamethasone uclear allergic appetite perforation;
acetate: leukocytes disorders and delayed diverticulitis; active
Initial:0.25-9 and , such as wound or latent peptic
mg/day in1-2 fibroblasts, rheumat healing; ulcer;
divided doses. and reversing oid hirsutism, inflammatory
Ophth Allergic capillary arthritis, bruising, bowel disease;
and permeability collagen striae, acne; CHF; hypertension;
inflammatory and diseases raised thromboembolic
conditions of lysosomal (eg, SLE), intracranial disorders;
the eye as 0.1% stabilization. dermatol pressure, osteoporosis;
soln: As Na ogic headache, seizure disorders;
phosphate: diseases depression, diabetes mellitus;
Instill 1-2 hrly (eg, psychosis, lactation
until symptoms pemphig menstrual
are controlled. us), irregularitie  Physical:
As0.1% oint: status s. Baseline weight, T,
As Na asthmati Hyperglyce reflexes and grip
phosphate: cus, and mia, strength, affect
Apply2-4 autoimm DM. and orientation, P,
times/day or at une Suppression BP, peripheral
night w/ the disorders of pituitary- perfusion,
eyedrops. adrenocorti prominence of
Topical Skin  Hematol cal axis. superficial veins,
disorders As ogic Growth Rand adventitious
dipropionate disorders retardation sounds, serum
(0.05%) or : in children electrolytes, blood
valerate (0.025 Thrombo (prolonged glucose
or 0.1%): Apply cytopeni therapy).
as directed a Increased Interventions
purpura, susceptibilit
erythrobl y for Systematic use
astopeni infections.
a Topical use:
 Give daily
Dermal
dose 9am
 Ulcerativ atrophy,
to mimic
e colitis, local
normal
acute irritation,
peak
exacerba folliculitis,
corticoste
tions of hypertricho
roid blood
MS, and sis.
levels.
palliation Inhalation:
 Increase
in some Hoarseness,
dosage
leukemia candidiasis
when
s and of mouth
patient is
lympho and
subject to
mas throat.
stress
Topical
 Taper
 Trichinos application
doses
is with to the eye:
when
neurolog Corneal
discontinu
ic or ulcers,
ing high
myocardi raised IOP
dose or
al and reduced long-term
involvem visual therapy
ent acuity.  Do not
Intradermal give live
injection: virus
Local vaccines
hypopigmen with
tation of immunos
deeply uppressiv
pigmented e doses of
skin. Intra- corticoste
articular roids.
injection:
Joint Topical
damage, dermatologic
fibrosis, esp. preparations
in load
bearing
joints Examine area for
infections and
skin integrity
before application

 Administ
er
cautiousl
y to
pregnant
patients’
topical
corticost
eroids
have
caused
teratoge
nic
effects
and can
be
absorbed
from
systemic
site.